5-HYDROXYINDOLACETIC ACID INCREASED

5-HYDROXYINDOLACETIC ACID INCREASED was reported 65 times

5-HYDROXYINDOLACETIC ACID INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Dipeptidyl Peptidase 4 Inhibitor [EPC] 20 0.0006
1 Sulfonylurea [EPC] 20 0.0002
2 Somatostatin Analog [EPC] 1 0.0001
3 Thiazide Diuretic [EPC] 22 0.0001
4 Topoisomerase Inhibitor [EPC] 5 0.0001
5 Prostaglandin E1 Analog [EPC] 1 0.0001
6 Vitamin D3 Analog [EPC] 1 0.0000
7 HMG-CoA Reductase Inhibitor [EPC] 16 0.0000
8 Aluminum Complex [EPC] 1 0.0000
9 Dihydropyridine Calcium Channel Blocker [EPC] 10 0.0000
10 Alkylating Drug [EPC] 6 0.0000
11 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
12 Kinase Inhibitor [EPC] 11 0.0000
13 Platinum-based Drug [EPC] 5 0.0000
14 Calcium [EPC] 2 0.0000
15 Anti-IgE [EPC] 1 0.0000
16 Azole Antifungal [EPC] 1 0.0000
17 Expectorant [EPC] 1 0.0000
18 Opioid Agonist [EPC] 1 0.0000
19 Factor Xa Inhibitor [EPC] 1 0.0000
20 Platelet Aggregation Inhibitor [EPC] 2 0.0000
21 Vitamin D [EPC] 1 0.0000
22 Vitamin B12 [EPC] 1 0.0000
23 Vitamin C [EPC] 1 0.0000
24 Insulin Analog [EPC] 1 0.0000
25 Loop Diuretic [EPC] 1 0.0000
26 Proton Pump Inhibitor [EPC] 1 0.0000
27 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
28 Benzodiazepine [EPC] 1 0.0000
29 Tumor Necrosis Factor Blocker [EPC] 1 0.0000